- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Puma Biotechnology, Inc.:
We consent to the incorporation by reference in the registration statements on Form S-8 (No. 333-181703, 333-196993, 333-205117, 333-218373, 333-219347, 333-236736 and 333-259585) and Form S-3 (No. 333-257687) of our report dated March 3, 2022, with respect to the consolidated balance sheets of Puma Biotechnology, Inc. as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive loss, stockholder’s deficit, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes, and the effectiveness of internal control over financial reporting as of December 31, 2021, which reports appear in the December 31, 2021 annual report for Form 10-K of Puma Biotechnology, Inc.
/s/ KPMG LLP
Los Angeles, California
March 3, 2022